TABLE 1.

Clinical and biochemical data from patients with skeletal and soft tissue sarcomas

Patient	Age (y)	Sex	Histogenesis	Grade	Location	Surgery	Microsatellite instability	Pretreatment	Status
Skeletal sarcomas
1	8	M	Osteosarcoma	High	Femur	Resection		Chemo	CDFS for 6 mo
2	48	M	Osteosarcoma	High	Tibia	Resection		Chemo	CDFS for 4 mo
3	69	M	Osteosarcoma	High	Femur	Amputation	D1S158, D11S861, D7S594, D17S786, D5S107	Chemo	DWD after 11 mo
4	53	F	Osteosarcoma	Low	Femur	Resection		None	CDFS for 6 mo
5	60	M	Hemangiopericytoma	Low	Scapula	Resection	DM	None	CDFS for 27 mo
6	47	M	Chondrosarcoma	High	Femur	Amputation	D13S170	None	DWD after 24 mo
Soft tissue sarcomas
7	65	F	Malignant fibrous histiocytoma	High	Thigh	Resection		XRT	AWD after 16 mo
8	65	F	Malignant fibrous histiocytoma*	High	Deltoid	Resection		Chemo	DWD after 2 mo
9	88	F	Malignant fibrous histiocytoma	High	Leg	Resection		None	AWD after 22 mo
10	36	F	Spindle cell sarcoma	Intermediate	Pelvis	Resection	DM	None	CDFS for 10 mo
11	34	M	Spindle cell sarcoma	Low	Deltoid	Resection	D5S107	None	CDFS for 15 mo
12	56	F	Liposarcoma (recurrence)	Low	Thigh	Resection		None	CDFS for 25 mo
13	57	M	Liposarcoma	High	Arm	Resection		XRT	CDFS for 10 mo
14	54	M	Fibrosarcoma	Intermediate	Thigh	Resection	D13S170, DM	None	CDFS for 22 mo
15	77	F	Neurofibrosarcoma (recurrence)	High	Thigh	Resection	D11S861, D11S904	XRT	DWD after 7 mo
16	33	M	Synovial sarcoma	High	Foot	Amputation		Chemo	CDFS for 5 mo

AWD, alive with disease; CDFS, continuous disease-free survival; Chemo, chemotherapy; DWD, dead with disease; XRT, radiotherapy.

^*Metastases on presentation.